Cash and cash equivalents (USD, thousands)

Marketable investments (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventories (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Operating lease right-of-use assets (USD, thousands)

Finance lease right-of-use assets (USD, thousands)

Intangible assets, net (USD, thousands)

Goodwill (USD, thousands)

Deferred taxes (USD, thousands)

Other non-current assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued liabilities (USD, thousands)

Current operating lease liabilities (USD, thousands)

Current finance lease liabilities (USD, thousands)

Total current liabilities (USD, thousands)

Non-current operating lease liabilities (USD, thousands)

Non-current finance lease liabilities (USD, thousands)

Other non-current liabilities (USD, thousands)

Total liabilities (USD, thousands)

Common stock (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive loss (USD, thousands)

Retained earnings (USD, thousands)

Total stockholders’ equity (USD, thousands)

Total liabilities and stockholders’ equity (USD, thousands)

c27ddf82e1b623fd2ee029bf25141132993d0ee9653605875daf080f03718eb0

Revenue (USD, thousands)

Cost of revenue (USD, thousands)

Gross profit (USD, thousands)

Research and development (USD, thousands)

Sales, general and administrative (USD, thousands)

Acquired in-process research and development (USD, thousands)

Impairment charge (USD, thousands)

Total operating expenses (USD, thousands)

Income (loss) from operations (USD, thousands)

Interest and other income (expense), net (USD, thousands)

Income (loss) before income taxes (USD, thousands)

Provision for (benefit from) income taxes (USD, thousands)

Net income (loss) (USD, thousands)

Net income (loss) per share - Basic (USD)

Net income (loss) per share - Diluted (USD)

Weighted average shares outstanding - Basic

Weighted average shares outstanding - Diluted

791ded3ccd933bdc90e1a03d799e6fe0075453b78fd4431ca710fc9ea54c7856

2e066925748dd65c801b982b54c59889e2550da8db838e21fe6d0fd23b5277bc

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

eb791db4e10adbd56c3ca8ce96b7fa33fc2534c0b8d0a92911f6ffaf0d60e867

United States

International

Total Revenue

daedd690defd9020db65fd4fb712d84a189144c8c201173c027cf8d35fba03f7

Total Revenue (USD, thousands)

Cost of Goods Sold (COGS) (USD, thousands)

SG&A (USD, thousands)

R&D (USD, thousands)

D&A (USD, thousands)

Interest Expense (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Net Income (USD, thousands)

EPS - Basic (USD/share)

EPS - Diluted (USD/share)

451eab05d9c0a8f714f4d54056b230b80d587f12e07d088dcd50a033249d63e0

Thrombectomy

Embolization and Access

Vascular

- Thrombectomy (Vascular)

- Embolization (Vascular)

Neuro

- Thrombectomy (Neuro)

- Embolization (Neuro)

- Access (Neuro)

95a9d62fe6b443f58bdb264d49142551f75aa26947a2ff752469570397776eae

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

d02ee6afe19408232231df448fdd249f9eb8153cc81455d799321258c2512e0d

Penumbra (PEN)

Financials